9 results
Algorithm for managing the failure of anti-TNF therapy. ADA=anti-drug antibody; IM=immunomodulator; MOA=mechanism of action; TNF=tumor necrosis
Algorithm for managing ... ADA=anti-drug antibody ... ; IM=immunomodulator ... factor #Management #GI ... #IM #IBD #AntiTNFFailure
Jaundice Evaluation Algorithm #Diagnosis #Management #EM #IM #GI #Jaundice #Hyperbilirubinemia #Workup #Evaluation #Differential #Algorithm #Direct #Indirect
Jaundice Evaluation ... Algorithm #Diagnosis ... Management #EM #IM ... #GI #Jaundice # ... #Differential #Algorithm
Fatigue and IBD Algorithm
 • 40-50% patients have fatigue despite clinical remission
 • Risk factors: BMI,
Algorithm • 40- ... Pearls: • IDA ... differentiate IDA ... modifications Algorithm ... #Algorithm #diagnosis
Upper and Lower Causes of GI Bleed
Upper:
 • Esophagus: Tear (Mallory Weiss, Boerhaave syndrome), Variceal, Esophagitis,
Lower Causes of GI ... colitis, UC/Chrons (IBD ... Radiation CMC IM ... diagnosis #Causes #algorithm
Vitamin B12 (Cobalamin) Deficiency
Etiology:
 • Vit B12 - aka cobalamin. Present in foods derived from animal
pernicious anemia, PA ... skin pallor • GI ... total body stores Evaluation ... symptoms • P/E - GI ... , can consider IM
UCSF COVID-19 Adult Clinical Evaluation Guide - Updated April 10 2020

Clinical Presentation
• Fever: hospitalized pts but
Adult Clinical Evaluation ... rhinorrhea) <20% • GI ... UCSF COVID-19 ID ... UCSF #COVID19 #Evaluation ... Guide #Diagnosis #Algorithm
Alcohol Use Disorder - Maintenance Treatment
Naltrexone (first line) - First line for most people without contraindications
qday OR 380 mg IM ... Dosing: Goal 150 mg BID ... TID Acamprosate (FDA ... TID Disulfiram (FDA
Immune Checkpoint Inhibitor-Mediated Colitis
Grade of Disease Severity:
 • G1: Increase < 4 BMs/day over baseline; mild
indicated Diagnostic Evaluation ... -4 • Consult GI ... diagnosis #management #algorithm ... #IBD
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
current treatment algorithm ... risk of clonal evolution ... Administration (FDA ... since decitabine’s FDA ... #algorithm #hematology